Beyond its important role in the antioxidant system, dietary intervention studies emphasize the regulatory function of NRF2 in lipid metabolism [10,11,12], identifying NRF2 as a potential therapeutic target in MASLD management. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.